Monte Rosa Therapeutics Inc.

09/11/2024 | Press release | Distributed by Public on 09/11/2024 12:19

6th Annual Inflammasome Summit – Exploring Novel Modalities: Disabling the NLRP3 Inflammasome with a NEK7 Molecular Glue Degrader